Skip to content
Biodatica
Start free

Investigator

Magnus Adrian Gero Hoffmann

J. DAVID GLADSTONE INSTITUTES · funded by NIAID, OD

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$4.5M

Summed across those awards.

First award
Jun 22, 2024

Latest Sep 26, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Transforming HIV vaccine design with a hybrid technology that leverages features of mRNA and protein nanoparticle platforms

    $3.6M

    Sep 26, 2025NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11161089 (opens the source filing in a new tab)

  2. DP5

    Self-Assembling Spike-EBR Nanoparticles as a Vaccine Platform Technology Against SARS-CoV-2 and Future Pandemic Coronaviruses

    $945k

    Jun 22, 2024ODJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11192352 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources